Stay updated with breaking news from D Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The S&P 500 also rose, gaining, 0.45% to 4,776.17.
The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
Velo3D, Inc. announced that the board of directors has commenced a strategic business review process to explore alternatives in order to maximize shareholder value. Potential strategic alternatives...
Benny Buller Steps Down as Chief Executive Officer – Will Remain on the Board of Directors Brad Kreger, EVP of Operations has Been Appointed as Interim Chief Executive Officer The Company has...